Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

• Autor(es): Rondy, Marc ; Kissling, Esther ; Emborg, Hanne-Dorthe ; Gherasim, Alin ; Pebody, Richard ; Trebbien, Ramona ; Pozo, Francisco ; Larrauri, Amparo ; McMenamin, Jim ; Valenciano, Marta ; I-Move/I-Move Group
• Data: 2018
• Identificador Persistente: http://hdl.handle.net/10400.18/5719
• Origem: Repositório Científico do Instituto Nacional de Saúde
• Assunto(s): Influenza Vaccine; Vacina Antigripal; Determinantes da Saúde e da Doença; Vaccine Effectiveness; Cuidados de Saúde; Europe; Case control study; Influenza; Influenza Vaccination; Influenza Vaccine Effectiveness; Multicentre Study
• Tipo de Documento: Artigo científico
• Idioma: Inglês
• Contribuidor(es): Repositório Científico do Instituto Nacional de Saúde

Descrição

Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.